Opko Health Inc. (NYSE:OPK) – Analysts at Jefferies Group boosted their FY2016 EPS estimates for Opko Health in a report released on Tuesday. Jefferies Group analyst B. Couillard now forecasts that the firm will post earnings of ($0.10) per share for the year, up from their previous estimate of ($0.12). Jefferies Group has a “Hold” rating and a $10.00 price target on the stock. Jefferies Group also issued estimates for Opko Health’s FY2017 earnings at ($0.08) EPS.

Opko Health (NYSE:OPK) last issued its earnings results on Monday, November 7th. The company reported ($0.03) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.03). The firm earned $298 million during the quarter, compared to analysts’ expectations of $322 million. Opko Health’s quarterly revenue was up 108.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.25 EPS.

Earnings History and Estimates for Opko Health (NYSE:OPK)

Other equities research analysts have also issued reports about the company. TheStreet lowered Opko Health from a “hold” rating to a “sell” rating in a research note on Wednesday. Oppenheimer Holdings Inc. reaffirmed a “market perform” rating on shares of Opko Health in a research report on Thursday, August 11th. JPMorgan Chase & Co. set a $14.00 target price on Opko Health and gave the stock a “buy” rating in a research report on Tuesday, August 9th. Finally, Zacks Investment Research downgraded Opko Health from a “hold” rating to a “sell” rating in a research report on Wednesday, October 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $13.20.

Shares of Opko Health (NYSE:OPK) opened at 9.38 on Thursday. Opko Health has a 12 month low of $7.12 and a 12 month high of $11.85. The stock has a market cap of $5.16 billion and a price-to-earnings ratio of 39.25. The company has a 50-day moving average price of $9.89 and a 200-day moving average price of $9.89.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ProShare Advisors LLC purchased a new position in Opko Health during the second quarter worth approximately $100,000. Financial Architects Inc increased its position in Opko Health by 21.5% in the second quarter. Financial Architects Inc now owns 10,950 shares of the company’s stock worth $102,000 after buying an additional 1,940 shares in the last quarter. First Citizens Bank & Trust Co. purchased a new position in Opko Health during the second quarter worth approximately $103,000. Williams Jones & Associates LLC increased its position in Opko Health by 352.0% in the second quarter. Williams Jones & Associates LLC now owns 11,300 shares of the company’s stock worth $106,000 after buying an additional 8,800 shares in the last quarter. Finally, IFC Holdings Incorporated FL purchased a new position in Opko Health during the third quarter worth approximately $113,000.

In other news, CEO Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock in a transaction on Monday, August 15th. The shares were bought at an average price of $10.07 per share, with a total value of $100,700.00. Following the acquisition, the chief executive officer now directly owns 3,068,951 shares in the company, valued at approximately $30,904,336.57. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

About Opko Health

OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.

5 Day Chart for NYSE:OPK

Receive News & Stock Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related stocks with our FREE daily email newsletter.